Skip to main content
International Wound Journal logoLink to International Wound Journal
. 2024 Apr 25;21(4):e14706. doi: 10.1111/iwj.14706

Risk factors and healing factors for pharyngocutaneous fistula after total laryngectomy for laryngeal cancer: An epidemiological study

Yong Tai 1, Yanzi Zang 1, Tongxun Liu 2, Jiqing Ma 1, Litao Qin 3, Yuzi Ji 1, Hanqing Dai 1, Guangke Wang 1, Lingcao Ma 1,, Fei Liu 1,
PMCID: PMC11044006  PMID: 38660912

Abstract

To analyse the risk factors and healing factors of pharyngocutaneous fistula (PCF) in patients with laryngeal cancer after total laryngectomy, and to explore the relevant epidemiology. A retrospective analysis was conducted on laryngeal cancer patients who underwent total laryngectomy in our hospital from January 2010 to December 2022. The 349 patients included in the study were divided into a PCF group of 79 and a non‐PCF group of 270. Perform one‐way analysis of variance and multivariate logistic analysis on various data of patients included in the statistics, and analyse the risk factors and healing factors of PCF. Smoking, history of radiation therapy for laryngeal cancer, history of chemotherapy for laryngeal cancer, tumour location (larynx, pharynx, oesophagus), preoperative albumin, postoperative proteinaemia, <99 haemoglobin, postoperative haemoglobin, postoperative C‐reactive protein (CRP) level are the risk factors for PCF. Also, radiation therapy and postoperative proteinaemia were the main reasons for preventing PCF healing. Smoking history, laryngeal cancer, radiation therapy, albumin, haemoglobin and CRP are risk factors for postoperative PCF after total laryngectomy, while radiation therapy and postoperative hypoalbuminaemia are key factors affecting PCF healing.

Keywords: an epidemiological study, laryngeal cancer, pharyngeal skin fistula, risk factors, total laryngectomy

1. INTRODUCTION

Laryngeal cancer is a malignant tumour that occurs in the throat and is more common in middle‐aged and elderly men. 1 The throat is the vocal organ of the human body, consisting of three parts: the glottis, supraglottis and infraglottis. 2 The symptoms of laryngeal cancer that grow on the vocal cords are obvious, and early symptoms include hoarseness. The early symptoms of laryngeal cancer that grows above or below the glottis are not obvious, mainly manifested as hoarseness, foreign body sensation and coughing. 3 , 4 As the tumour grows, it may experience breathing difficulties, excessive coughing, swallowing difficulties, neck pain or swelling, and so forth. In clinical practice, surgical resection is the main treatment for laryngeal cancer, with radiation therapy as an adjuvant treatment. 5 For laryngeal cancer that invades the vocal cords, supraglottis, subglottis, epiglottis and other areas, total laryngectomy surgery should be performed as soon as possible. 6 For early stage laryngeal cancer patients with small tumour invasion sites, semi laryngectomy can be performed.

Pharyngeal skin fistula (PCF) after hypopharyngeal and total laryngectomy is an early postoperative complication with a high incidence rate of over 20%. 7 PCF is a fistula formed by the connection between the pharyngeal cavity and the skin of the neck, which means that the surgical incision cannot be healed. There are many risk factors for the formation of PCF, and perioperative care for total laryngectomy requires special attention to these factors. Kim et al. 8 QUADAS‐2 was used to assess the risk factors of laryngopharyngeal fistula after total laryngectomy in 9845 patients. The results showed that there was a significant correlation between the occurrence of PCF and age, postoperative anaemia, diabetes, tumour site (above or below the glottis), previous radiotherapy, previous tracheostomy, operation time, extended total laryngectomy, primary tracheoesophageal puncture and postoperative hypoproteinaemia. Among them, The most accurate predictor of pharyngocutaneous fistula (PCF) occurrence is postoperative hypoalbuminaemia. Michael et al. 9 analysed patients with primary and salvage laryngectomy for the treatment of laryngeal squamous cell carcinoma and hypopharyngeal squamous cell carcinoma, summarized the relevant factors for the formation of PCF, and conducted a retrospective analysis of 127 total laryngectomy patients. The data of 127 patients with total laryngectomy were retrospectively analysed. The risk factors for PCF were female, hypopharyngeal cancer, positive surgical margin and tumour extension to pink mucosa. Preoperative radiotherapy has a certain impact on the formation of PCF, but there is no statistical significance. Casasayas et al. 10 conducted a retrospective analysis of 171 pairs of patients who underwent total laryngectomy after radiotherapy or chemotherapy. It was found that 33 cases (19.3%) of patients developed PCFs, and patients who received radiotherapy and chemotherapy had PCFs that needed repair were significantly higher than those who only received radiotherapy. Studies have shown that 10 the significance of the incidence of PCFs depends on the time interval between radiotherapy and surgery. In recent years, there have been many studies on the risk factors of PCF. In this article, we searched the global laryngeal cancer database and conducted epidemiological statistics to summarize the risk factors of PCF after total laryngectomy, hoping to contribute to the prevention of PCF.

2. METHODS

2.1. Patients

We conducted a retrospective analysis of the treatment records of laryngeal cancer patients who underwent total laryngectomy in our hospital from January 2010 to December 2022. This study was approved by the ethics committee of the author's hospital, and all patients included in the study agreed to disclose treatment data. Three hundred and fifty‐six patients underwent total laryngectomy, while 79 patients developed PCF after total laryngectomy. Seven individuals underwent tongue root resection surgery simultaneously and were excluded from the study. This study was divided into two groups, with 79 individuals in the PCF group and 270 individuals in the non‐PCF group. All laryngeal cancer patients with PCF will undergo follow‐up examination 4 weeks after total laryngectomy, and their healing status will be evaluated.

2.2. Definition, aetiology and clinical manifestations of PCF

Pharyngocutaneous fistula refers to a fistula formed during total laryngectomy, where the surgical incision cannot heal due to various reasons, and the pharyngeal cavity communicates with the skin of the neck. 11 The clinical manifestation of PCF is that saliva is stored in the subcutaneous or incision tissue, forming a purulent cavity that ruptures to the skin or incision edge, allowing the pharyngeal, oesophageal and skin to enter the sinus tract, and through this, saliva or food can overflow to the skin. 12 , 13 The formation of PCF may be due to the patient's underlying disease, or excessive excision of the pharyngeal mucosa during surgery, resulting in excessive tension during suturing; Either the tight suture leads to mucosal ischaemic necrosis or secondary infection, or the patient has poor wound healing ability after radiotherapy, or improper postoperative diet. 14 , 15 After the formation of PCF, it can generally self‐heal within 4 weeks. If the larger PCF does not heal for more than 4 weeks, it can be repaired surgically. 16 After total resection of laryngeal cancer, it is important to strengthen nutrition, prevent infection and avoid swallowing oral secretions as much as possible to prevent or reduce the formation of PCF. 14

2.3. Data statistics and processing

Age, gender, BMI, smoking, drinking, history of diabetes, history of hypertension, throat abnormalities, history of thyroid diseases, chronic obstructive pulmonary disease (COPD), gastroesophageal reflex disease, history of radiation therapy for laryngeal cancer, history of chemotherapy for laryngeal cancer, tumour location, tumour staging, surgical recovery time, neck section, tracheotitis Omy, type of surgery, preoperative white blood cell count, postoperative white blood cell count, preoperative albumin, postoperative albumin, preoperative proteinaemia, postoperative proteinaemia, preoperative haemoglobin, postoperative haemoglobin, preoperative C‐reactive protein (CRP) level, postoperative CRP level were counted and compared between the PCF and non‐PCF groups.

IBM SPSS Statistics 25.0 software was used to analysed the data. Continuous data are represented by mean ± standard deviation, binary data are represented by n and percentages are statistically analysed. The comparison of variables between the two groups is tested using one‐way ANOVA, 17 , 18 and a p‐value <0.05 indicates statistical significance. The significance of ANOVA is used as the p‐value for data that satisfies normal distribution and homogeneity of variance tests. The significance of Welch or Brown‐Forsyth is used as the p‐value for data that does not meet the requirement of homogeneity of variance. The comparison between multiple groups of variables was detected using multivariate logistic regression analysis, 19 and p < 0.05 indicates statistical significance.

3. RESULTS

3.1. Various indicators before and after total laryngectomy for patients

The various indicators before and after total laryngectomy for patients in the PCF group and non PCF group were statistically and listed for comparison, as shown in Table 1. The results showed sex, BMI, smoking, COPD, history of radiation therapy for lunar cancer, history of chemotherapy for lunar cancer, tumour location (larynx, pharynx, oesophagus), surgical recovery time, type of surgery (simple TL, TLPP without PMMF, TLPP‐TLTP with PMMF), preoperative albumin (≤35, >35) and postoperative proteinaemia. The differences between the two groups of preoperative haemoglobin (>115, 99–115, <99), postoperative haemoglobin (>115, 99–115, <99) and postoperative CRP level (<40, ≥40) were statistically significant, while the p‐values of other indicators were >0.05, indicating no statistically significant difference.

TABLE 1.

Clinical indicators of patients undergoing total laryngectomy (n = 349).

Clinical indicators Total Non PCF PCF p value
Patients number 349 270 79
Age (yeas, mean ± SD) 64.5 ± 9.67 63.9 ± 10.5 65.7 ± 10.8 0.140
Sex (Male, n, %) 285 228 57 0.003
Sex (Female, n, %) 64 42 22 0.005
BMI (kg/m2, mean ± SD) 22.75 ± 2.79 23.68 ± 2.01 21.88 ± 2.23 0.030
Smoking (n, %) 233 194 39 0.020
Drinking (n, %) 258 222 36 0.060
History of diabetes (n, %) 169 150 19 0.510
History of hypertension (n, %) 266 225 41 0.660
Thyroid abnormalities, history of thyroid diseases (n, %) 177 159 18 0.230
COPD (n, %) 69 54 15 0.010
Gastroesophageal reflux disease (n, %) 73 62 11 0.780
History of radiation therapy for laryngeal cancer (n, %) 189 140 49 0.001
History of chemotherapy for laryngeal cancer (n, %) 171 133 38 0.011
Tumour location (n, %)
Larynx 174 144 30 0.024
Pharynx 147 104 43 0.047
Oesophagus 12 9 3 0.019
Thyroid 9 7 2 0.054
Others 7 6 1 0.055
Tumour staging (n, %)
T1 86 74 12 0.976
T2 90 79 21 0.889
T3 120 89 31 0.543
T4 53 28 15 0.566
N0 108 85 23 0.901
N1 97 81 16 0.833
N2 121 92 29 0.359
N3 23 14 9 0.367
Surgical resection time (min, mean ± SD) 350.7 ± 197.2 378.9 ± 201.5 309 ± 199.3 0.040
Neck dissection (n, %)
Non 77 61 16 0.420
Unilateral 127 96 31 0.230
Bilateral 145 113 32 0.170
Tracheotomy (n, %) 166 143 23 0.560
Type of surgery (n, %)
Simple TL 52 40 12 0.031
TLPP without PMMF 134 102 32 0.027
TLPP–TLTP with PMMF 163 128 35 0.042
Preoperative white blood cell count (109/L) 9.22 ± 1.01 8.93 ± 1.66 9.31 ± 1.48 0.27
Postoperative white blood cell count (109/L) 9.37 ± 1.21 9.47 ± 1.33 9.36 ± 1.45 0.19
Preoperative albumin (g/L, n, %)
≤35 134 103 31 <0.001
>35 215 167 48 <0.001
Postoperative albumin (g/L, n, %)
≤35 251 199 52 0.117
>35 98 71 27 0.074
Preoperative proteinaemia (n, %) 143 109 34 0.211
Postoperative proteinaemia (n, %) 267 210 57 0.029
Preoperative haemoglobin (g/L, n, %)
>115 91 73 18 0.001
99–115 133 106 27 0.007
<99 125 91 34 0.003
Postoperative haemoglobin (g/L, n, %)
>115 69 56 13 0.001
99–115 116 95 21 0.001
<99 164 128 36 0.005
Preoperative CRP level (mg/L, n, %)
<40 348 270 78 0.131
≥40 1 0 1 0.227
Postoperative CRP level (mg/L, n, %)
<40 72 61 11 0.019
≥40 277 209 68 0.028

Abbreviations: COPD, chronic obstructive pulmonary disease; CRP, C‐reactive protein; PCF, pharyngocutaneous fistula; PMMF, pectoralis major myocutaneous flap; TL, total laryngectomy; TLPP, total laryngectomy with partial pharyngectomy. TLTP, total laryngectomy with total pharyngectomy. Tumour staging, The T‐grade determines the condition of primary laryngeal cancer, the N‐grade determines the extent of regional lymph node invasion.

3.2. Multivariate logistic regression analysis

Multivariate logistic regression analysis was performed on the indicators with statistical differences between the PCF group and the non PCF group, as shown in Table 2. The results showed that smoking, history of radiation therapy for laryngeal cancer, history of chemotherapy for laryngeal cancer, tumour location (larynx, pharynx, oesophagus), preoperative albumin, postoperative proteinaemia, <99 haemoglobin, postoperative haemoglobin, and postoperative CRP level are literature factors for PCF after total laryngectomy.

TABLE 2.

Multivariate logistic regression analysis of risk factors for pharyngocutaneous fistula after total laryngectomy (N = 349).

Multivariate logistic regression analysis
HR 95% CI p‐value
Sex 0.935 0.912–1.059 0.087
Sex 0.961 0.919–1.073 0.072
BMI 0.911 0.892–1.067 0.065
Smoking 2.375 2.098–2.713 0.016
COPD 0.714 0.681–0.796 0.374
History of radiation therapy for laryngeal cancer 5.932 4.178–7.035 0.001
History of chemotherapy for laryngeal cancer 4.823 3.489–6.193 0.012
Tumour location (n, %)
Larynx 1.670 1.502–1.731 0.011
Pharynx 1.036 0.997–1.184 0.025
Oesophagus 1.939 1.733–2.187 0.028
Surgical resection time 0.979 0.910–1.544 0.691
Type of surgery
Simple TL 6.922 6.801–7.032 0.748
TLPP without PMMF 4.877 4.605–5.008 0.369
TLPP–TLTP with PMMF 4.923 4.770–5.120 0.655
Preoperative albumin
≤35 0.923 0.866–1.021 0.037
>35 0.992 0.812–1.057 0.048
Postoperative proteinaemia 0.910 0.843–0.995 0.033
Preoperative haemoglobin
>115 5.091 5.623–5.389 0.293
99–115 3.056 2.988–3.237 0.311
<99 0.937 0.873–1.012 0.043
Postoperative CRP level
<40 1.575 1.384–1.803 0.017
≥40 0.935 0.902–0.973 0.034

Abbreviations: COPD, chronic obstructive pulmonary disease; CRP, C‐reactive protein; PMMF, pectoralis major myocutaneous flap; TL, total laryngectomy; TLPP, total laryngectomy with partial pharyngectomy. TLTP, total laryngectomy with total pharyngectomy.

3.3. Healing status of PCF at 4 weeks after surgery

Seventy‐one patients with PCF returned to the hospital for healing examination 4 weeks after total laryngectomy, as shown in Table 3. The results showed that there were 68 patients with PCF healing >80%, accounting for 86.08% of the total number of PCFs. Twelve patients (15.19%) had a numerical rating scale score of ≥4 for PCF pain, indicating moderate or severe pain. Among them, one patient's pain was caused by touching the PCF on the same day. Nine (11.39%) patients with unhealed PCF experienced wound exudation, and two (2.53%) patients with unhealed PCF experienced infection. The 11 patients with non‐healing PCF were all treated with radiotherapy before or after surgery and were all with post‐operative hypoproteinaemia.

TABLE 3.

Healing of pharyngeal fistula after total laryngectomy (n = 79).

Clinical indicators PCF
Patients number 79
Wound healing >80% at 4 weeks post‐surgery (n, %) 68, 86.08
Wound pain (NRS score ≥4, n, %) 12, 15.19
Wound exudate (n, %) 9, 11.39
Fistula infection (n, %) 2, 2.53

Note: There are a total of 11 rating levels, with 0 indicating no pain, 1–3 indicating mild pain, 4–6 indicating moderate pain and 7–10 indicating severe pain.

Abbreviations: NRS, numerical rating scale; PCF, pharyngocutaneous fistula.

3.4. Implementing elastic network regression model with python

The risk score has better judgement and calibration ability in the learning population and the validation population. The AUC of learning ability was 0.68 (95% CI 1/4 0.68–0.78) and the AUC of the validated population was 0.71 (95% CI 1/4 0.62–0.80). The average and maximum errors of the learning population were 0.04 and 0.15 respectively. The average and maximum errors of the verified population were 0.07 and 0.23 respectively. The calibration prediction curve and the standard curve fit well, suggesting that the risk score has a good consistency between the predicted probability and the actual probability of patients with pharyngeal cutaneous fistula after total laryngectomy, and the higher the value, the stronger the correlation (shown in Figure 1).

FIGURE 1.

FIGURE 1

Elastic net/bootstrap selection stability. Calibration: A, learning population; B, Validation population.

4. DISCUSSION

The malignancy of laryngeal cancer is very high, but the 5‐year survival rate of early stage laryngeal cancer can reach 70%–80% through simple surgical treatment, 20 , 21 and the 5‐year survival rate of mid to late stage laryngeal cancer can also reach over 50%. With the constant change in medical environment and individual differences, postoperative complications are different laryngeal cancer surgery is becoming increasingly sophisticated. Laccourreye et al. 22 conducted an observational retrospective analysis using the STROBE guideline to compare the survival rate, estimated local control, mortality rate and adjuvant therapy between two groups of patients undergoing total laryngectomy at different time intervals of 130 years. The results showed that in recent years, the survival rate of total laryngectomy for laryngeal cancer has significantly improved by more than 50% compared to before, and the 5‐year actuarial local control estimate has increased to 83.7%. The mortality rate caused by postoperative complications significantly decreased, and the majority of patients received adjuvant treatment methods such as neck lymph node dissection and postoperative radiotherapy, with 50% of survivors implanted with speech devices. The survival status of laryngeal cancer patients has been significantly improved. Early laryngeal cancer 23 , 24 can be treated with hemilaryngectomy, preserving some of the laryngeal organs. Lee et al. 25 A retrospective analysis of 119 patients with organ preservation (OP) compared stage I total laryngectomy and OP in patients with locally advanced T3/T4a laryngeal cancer The overall survival rates of total laryngectomy and OP patients were similar, with most patients able to maintain a normal diet after total laryngectomy and a higher local recurrence rate in OP patients. Despite the continuous improvement of surgical methods, there are still many postoperative complications.

PCF is the most common complication after total laryngectomy. PCF refers to the formation of a pus cavity under the subcutaneous or total laryngectomy incision, which ruptures to the skin or incision edge, allowing the pharyngeal and oesophageal cavities to connect with the skin and form a sinus. Ferreli et al. 26 analysed six patients with recurrent/residual squamous cell carcinoma after chemotherapy or radiotherapy for total laryngectomy using a lateral cervical approach, in which pre‐laryngeal tissue was preserved and found that PCF was mainly associated with infection, residual tumours, excessive tension at the surgical site, malnutrition and poor suture techniques. There are currently many methods for treating PCF in clinical practice. Chen et al. 27 reviewed the most common complication after total laryngectomy, PCF, and found that adding growth factors can promote fibroblast proliferation, angiogenesis and accelerate wound healing. Currently, there is a nanoscale extracellular vesicle of extracellular vesicles that can promote angiogenesis, protein polysaccharides and collagen deposition, thereby promoting wound healing. Matsuo et al. 28 used molecular targeting technology to treat two cases of delayed PCF. Two laryngeal cancer patients developed delayed PCF 3 and 25 months after total laryngectomy respectively. Two patients received vascular endothelial growth factor receptor inhibitor R and platelet‐derived growth factor receptor inhibitor R respectively. The treatment effect of inhibitors is very good. Hu et al. 29 studied a technique for transnasal negative pressure therapy (TNPT) for PCF after total laryngectomy for laryngeal cancer. The study retrospectively analysed 47 patients who developed PCF after total laryngectomy from April 2015 to February 2021. The healing rate, dressing frequency, healing time and 2‐year overall survival rate of the TNPT group and non‐TNPT group were compared, and the results showed that the dressing frequency of the TNPT group was significantly reduced compared to the non‐TNPT group. The healing time was significantly shortened and the 2‐year survival rate was significantly improved. TNPT can promote wound healing. Matsumoto et al. 30 conducted endoscopic observation of the pharyngeal mucosal sutures in patients with primary total laryngectomy and found that all patients had a white coating attached to the pharyngeal mucosal sutures after surgery. The gradual disappearance of the white coating is a normal healing process. If the white coating thickens or cannot disappear, it indicates poor healing conditions of the surgical incision. Researchers have observed that such patients are more prone to PCF. Endoscopic observation can detect potential PCF early and prevent PCF. 31 There are various methods for prevention and treatment of pharyngeal cutaneous fistula, so it is very important to find out the risk factors and healing factors for the occurrence and development of laryngeal cutaneous fistula after total laryngectomy for laryngeal cancer.

In this study, patients with laryngeal cancer undergoing total laryngectomy were analysed and the indicators of PCF group and non‐PCF group were compared. We found that one‐way ANOVA measured differences between the two groups, sex, BMI, smoking, COPD, history of radiation therapy for lunar cancer, history of chemotherapy for lunar cancer, tumour location, surgical recovery time, type of surgery, preoperative albumin, postoperative proteinaemia, preoperative haemoglobin, postoperative haemoglobin and postoperative CRP levels are possible risk factors for PCF. Multivariate logistic regression analysis showed that smoking, history of radiation therapy or laryngeal cancer, history of chemotherapy for laryngeal cancer, tumour location (larynx, pharynx, oesophagus), preoperative albumin, postoperative proteinaemia, <99 haemoglobin, postoperative haemoglobin, and postoperative CRP level is a risk factor for PCF. Pankhania et al. 32 reported that the risk of pharyngeal inflammation lies in the rapid damage caused by smoking to the posterior pharyngeal wall. To a certain extent, the harm caused by smoking on pharyngeal tract is explained, but there are few reports on the effect of smoking on pharyngeal tract fistula. In this study, long‐term smoking is one of the risk factors affecting the formation of pharyngeal tract fistula through statistical analysis. Studies 33 , 34 , 35 , 36 , 37 , 38 have shown that tumour recurrence may affect the local blood supply, postoperative pharyngeal residual less normal mucosa, postoperative incision margin wound infection, and so forth, may increase the occurrence of pharyngeal fistula. The decrease in postoperative haemoglobin indicates the occurrence of PCF. Close observation of postoperative blood routine changes is conducive to early diagnosis of PCF. The results of 4 weeks' post‐operative examination showed that radiation therapy and postoperative proteinaemia were the main reasons for preventing PCF healing. Severe hypoproteinaemia occurs, the body's plasma colloid osmotic pressure drops, a large amount of liquid is stored in the local tissue space of the wound, the blood perfusion volume is reduced and the repair and renewal function of cells and tissues is hindered. 39 This is basically consistent with our research conclusions. Our study has important significance for the occurrence and healing of PCF after total laryngectomy.

This study searched and collected data from a cancer database. The publicly available records in the database are from many years ago, which may differ from the recent occurrence and development of laryngeal cancer. With the improvement of nursing methods, there may be new advances in the treatment of complications such as PCF after total laryngectomy, and the exploration of risk factors may have new directions. This study can only reflect the situation of laryngeal cancer patients in the database, and cannot obtain the latest epidemiological statistics. This article has certain reference values for the risk factors of PCF, but data collection is limited and the latest global data has not been collected. In subsequent research, we should review the latest published literature on PCF after total laryngectomy, obtain a ranking of risk factors and guide clinical prevention and treatment.

5. CONCLUSION

Our research shows that smoking, history of radiation therapy for lunar cancer, history of chemotherapy for lunar cancer, tumour location, preoperative albumin, postoperative proteinaemia, preoperative hemisphere, postoperative CRP Level is a risk factor for PCF after total laryngectomy, and postoperative radiotherapy and preoperative hypoproteinaemia are likely to be important factors hindering the healing of PCF.

FUNDING INFORMATION

The research received funding from the Medical Science and Technology Tackling Programme Project of Henan Province under the grant LHGJ20230045.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

ETHICS STATEMENT

The present study was approved by the Care and Use Committee of Henan Provincial People's Hospital, Henan University.

Tai Y, Zang Y, Liu T, et al. Risk factors and healing factors for pharyngocutaneous fistula after total laryngectomy for laryngeal cancer: An epidemiological study. Int Wound J. 2024;21(4):e14706. doi: 10.1111/iwj.14706

Yong Tai and Yanzi Zang are co‐first authors.

Contributor Information

Lingcao Ma, Email: ma1330322179@qq.com.

Fei Liu, Email: ebh009391@126.com.

DATA AVAILABILITY STATEMENT

Availability of data and materialsThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

REFERENCES

  • 1. Koroulakis A, Agarwal M. Laryngeal Cancer. StatPearls; 2023. [PubMed] [Google Scholar]
  • 2. Shaker K, Winters R, Jones EB. Laryngeal Injury. StatPearls; 2023. [PubMed] [Google Scholar]
  • 3. Goh Co Ian J, Huang X, Pang MJ, Lee TS. Convulsive syncope from carotid sinus syndrome as a manifestation of laryngeal cancer. Ann Otol Rhinol Laryngol. 2023;132(1):100‐104. [DOI] [PubMed] [Google Scholar]
  • 4. Hrelec C. Management of laryngeal dysplasia and early invasive cancer. Curr Treat Options Oncol. 2021;22(10):90. [DOI] [PubMed] [Google Scholar]
  • 5. Bootz F. Guideline on diagnosis, treatment, and follow‐up of laryngeal cancer. Radiologe. 2020;68(10):757‐762. [DOI] [PubMed] [Google Scholar]
  • 6. van Uden‐Kraan CF, Jansen F, Lissenberg‐Witte BI, Eerenstein SEJ, Leemans CR, Verdonck‐de Leeuw IM. Health‐related and cancer‐related internet use by patients treated with total laryngectomy. Support Care Cancer. 2020;28(1):131‐140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Algargaz W, Mohamad I, Eid S, Khanfa A, Abushukair H. Stapler pharyngeal repair versus conventional suturing after laryngectomy in Jordanian laryngeal cancer patients. Med Arch. 2022;76(5):363‐367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Kim DH, Kim SW, Hwang SH. Predictive value of risk factors for pharyngocutaneous fistula after total laryngectomy. Laryngoscope. 2023;133(4):742‐754. [DOI] [PubMed] [Google Scholar]
  • 9. Michael RC, das S, Mani S, et al. Pharyngocutaneous fistula following primary and salvage laryngectomy: aetiology and predictive factors. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):2139‐2148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Casasayas M, Sansa A, García‐Lorenzo J, Venegas MP, Quer M, León X. Pharyngocutaneous fistula in irradiated patients: systematic review and our experience. J Laryngol Otol. 2022;136(11):1027‐1033. [DOI] [PubMed] [Google Scholar]
  • 11. Chiu TH, Shih HS, Jeng SF. A review of pharyngocutaneous fistula management in head and neck malignancies. Ann Palliat Med. 2023;12(5):1081‐1088. [DOI] [PubMed] [Google Scholar]
  • 12. Peneda JF, Fernandes J, Monteiro E. Pharyngocutaneous fistula following total laryngectomy: a high‐volume tertiary centre series. Indian J Surg Oncol. 2023;14(3):742‐748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Heo Y, Lee HS, Jung S, et al. Improved early detection models of pharyngocutaneous fistula after total laryngectomy. J Clin Med. 2023;12(5):1851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Dong YB, Yuan LN, Luo JK, et al. Delayed oral feeding reduces pharyngocutaneous fistula formation after open surgical treatment of primary hypopharyngeal cancer: a case‐control study. Ear Nose Throat J. 2022;1455613221136359. [DOI] [PubMed] [Google Scholar]
  • 15. Jichao S, Cuida M, Liwei S, Jiani L, Dongdong Z. Predictive value of procalcitonin level for pharyngocutaneous fistula after laryngectomy. Am J Otolaryngol. 2023;44(4):103846. [DOI] [PubMed] [Google Scholar]
  • 16. Al‐Wageeh S, Ahmed F, Alyhari Q, Mohammed F. Synchronous cervical necrotizing fasciitis and pharyngocutaneous fistula: a case report. Int J Surg Case Rep. 2022;93:106988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Aladraj TH, Keshta AS, Mukhtar I, Zeidan AA, Abousaleh MA, Ali N. A retrospective cohort study comparing the outcomes of conservative versus operative fixation of distal radius fractures in children. Cureus. 2022;14(2):e22544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Chatzi A, Doody O. The one‐way ANOVA test explained. Nurse Res. 2023;31(3):8‐14. [DOI] [PubMed] [Google Scholar]
  • 19. Wang W, Fan D, Quan B, Hou W, Yang J. Logistic regression analysis of risk factors for hemorrhagic fever with renal syndrome complicated with acute pancreatitis. Ann Med. 2023;55(1):2232355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Sanders O, Pathak S. Hypopharyngeal Cancer. StatPearls; 2023. [PubMed] [Google Scholar]
  • 21. Molina‐Fernandez E, Palacios‐García JM, Moreno‐Luna R, et al. Survival analysis in patients with laryngeal cancer: a retrospective cohort study. Life. 2023;13(2):295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Laccourreye O, Garcia D, Mudry A. Total laryngectomy for laryngeal cancer 150 years after its first description: a boon more than a calamity: a STROBE analysis. Eur Ann Otorhinolaryngol Head Neck Dis. 2023;140(1):25‐29. [DOI] [PubMed] [Google Scholar]
  • 23. Hans S, Baudouin R, Circiu MP, et al. Open partial laryngectomies: history of laryngeal cancer surgery. J Clin Med. 2022;11(18):5352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Wang Y, Liu D, She C. Clinical diagnosis and treatment of primary laryngeal neuroendocrine carcinoma. Ear Nose Throat J. 2023;1455613231155853. [DOI] [PubMed] [Google Scholar]
  • 25. Lee MY, Belfiglio M, Zeng J, et al. Primary total laryngectomy versus organ preservation for locally advanced T3/T4a laryngeal cancer. Laryngoscope. 2023;133(5):1122‐1131. [DOI] [PubMed] [Google Scholar]
  • 26. Ferreli F, Mercante G, de Virgilio A, et al. Lateral cervical approach for salvage total laryngectomy without pharyngeal reinforcement with pedicled or free flaps: our preliminary experience in six patients. Eur Arch Otorhinolaryngol. 2020;277(6):1837‐1841. [DOI] [PubMed] [Google Scholar]
  • 27. Chen L, Wang M, Zhong Z, et al. Role of exosomes in pharyngucutaneous fistula after total laryngectomy. Int J Nanomedicine. 2022;17:4119‐4135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Matsuo M, Hashimoto K, Jiromaru R, Nakagawa T. Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report. J Med Case Reports. 2022;16(1):383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Hu Z, Guo X, Chen L, Lei W. Transnasal negative pressure therapy for accelerating healing and improving the prognosis of pharyngocutaneous fistula. Head Neck. 2023;45(11):2809‐2818. [DOI] [PubMed] [Google Scholar]
  • 30. Matsumoto S, Nakayama M, Fujii K, Adachi M, Shima Y, Tabuchi K. Endoscopic observation of pharyngeal mucosal suture healing process after total laryngectomy: case series. Acta Otolaryngol. 2023;143(5):434‐439. [DOI] [PubMed] [Google Scholar]
  • 31. Nakajo K, Ninomiya Y, Kondo H, et al. Anatomical classification of pharyngeal and laryngeal endoscopic images using artificial intelligence. Head Neck. 2023;45(6):1549‐1557. [DOI] [PubMed] [Google Scholar]
  • 32. Pankhania R, Liu A, Grounds R. Oropharyngeal bleeding due to cannabidiol oil vape use. Cureus. 2021;13(1):e12676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Wang M, Xun Y, Wang K, et al. Risk factors of pharyngocutaneous fistula after total laryngectomy: a systematic review and meta‐analysis. Eur Arch Otorhinolaryngol. 2020;277(2):585‐599. [DOI] [PubMed] [Google Scholar]
  • 34. Lemaire E, Schultz P, Vergez S, et al. Risk factors for pharyngocutaneous fistula after total pharyngolaryngectomy. Ear Nose Throat J. 2021;100(5_suppl):746S‐752S. [DOI] [PubMed] [Google Scholar]
  • 35. Peneda JF, Fernandes J, Monteiro E. Risk factors for pharyngocutaneous fistula following total laryngectomy. Indian J Otolaryngol Head Neck Surg. 2023;75(2):485‐491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Dejaco D, Rauchenwald T, Steinbichler T, et al. Fistelprophylaxe mit muskelsparendem, myofaszialem Pectoralis‐major‐Lappen bei Salvage‐Laryngektomie [fistula prophylaxis with muscle‐sparing, myofascial pectoralis major lobe in salvage laryngectomy]. Laryngorhinootologie. 2020;99(4):229‐236. [DOI] [PubMed] [Google Scholar]
  • 37. Chotipanich A, Wongmanee S. Incidence of pharyngocutaneous fistula after total laryngectomy and its relationship with the shapes of mucosa closure: a meta‐analysis. Cureus. 2022;14(9):e28822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Nassar AA. Mapping the risk factors of pharyngocutaneous fistula after salvage laryngectomies. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 3):5954‐5958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Wiedermann CJ. Hypoalbuminemia as surrogate and culprit of infections. Int J Mol Sci. 2021;22(9):4496. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Availability of data and materialsThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from International Wound Journal are provided here courtesy of Wiley

RESOURCES